Journal rankings · indicator year 2015
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2015
Endocrinology, Diabetes and Metabolism journal rankings 2015
141 ranked journals · Subfield in Medicine
Endocrinology, Diabetes and Metabolism has 141 ranked journals in 2015. The median journal has an OJR of 0.96, below the world average of 1.00, down 0.01 on 2014; Q1 starts at OJR 1.50. The top three are Endocrine Reviews, Diabetes Care, and The Lancet Diabetes & Endocrinology.
Ranks and citation indicators: 2015. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2012–2014, the window the 2015 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery773
- Pulmonary and Respiratory Medicine297
- Public Health, Environmental and Occupational Health252
- Cardiology and Cardiovascular Medicine238
- Oncology188
- Infectious Diseases182
- Epidemiology176
- Neurology151
- Endocrinology, Diabetes and Metabolism141
- Radiology, Nuclear Medicine and Imaging138
- Physiology129
- Psychiatry and Mental health123
Show all 42 subfields
- Orthopedics and Sports Medicine95
- Pediatrics, Perinatology and Child Health85
- Dermatology74
- Ophthalmology74
- Hematology71
- Obstetrics and Gynecology61
- Rheumatology58
- Nephrology49
- Reproductive Medicine45
- Complementary and alternative medicine42
- Pharmacology42
- Emergency Medicine36
- Geriatrics and Gerontology36
- Otorhinolaryngology34
- Rehabilitation29
- Pathology and Forensic Medicine23
- Critical Care and Intensive Care Medicine22
- Genetics19
- Hepatology19
- Immunology and Allergy17
- Anesthesiology and Pain Medicine12
- Urology11
- Gastroenterology6
- Internal Medicine5
- Family Practice3
- Transplantation3
- Health Informatics1
- Anatomy0
- Biochemistry0
- Microbiology0
141 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2014. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2012–2014, the window the 2015 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2012–2014 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2006 to 2015. | Compare |
|---|---|---|---|---|---|---|---|
1Endocrine ReviewsOxford University Press · United States | 8.50Q1 | 17.92 2.70 down from 2014 | 90 | 36% | $3,750 | ||
2Diabetes CareAmerican Diabetes Association · United States | 4.39Q1 | 9.52 0.01 up from 2014 | 1,891 | 50% | — | ||
3The Lancet Diabetes & EndocrinologyElsevier BV · Netherlands | 4.36Q1 | 9.36 2.64 up from 2014 | 278 | 41% | $7,280 | ||
4The Journal of Clinical Endocrinology & MetabolismOxford University Press · United States | 3.08Q1 | 6.62 0.86 down from 2014 | 2,735 | 48% | $3,750 | ||
5Best Practice & Research Clinical Endocrinology & MetabolismElsevier BV · United Kingdom | 3.02Q1 | 6.43 0.23 up from 2014 | 219 | 13% | $4,450 | ||
6Diabetes Obesity and MetabolismWiley · United Kingdom | 2.94Q1 | 7.10 1.27 down from 2014 | 506 | 47% | $5,380 | ||
7DiabetologiaSpringer Science+Business Media · Germany | 2.90Q1 | 6.12 1.66 down from 2014 | 1,008 | 85% | $3,490 | ||
8Journal of Internal MedicineWiley · United Kingdom | 2.87Q1 | 7.18 1.40 up from 2014 | 406 | 71% | $4,780 | ||
9Reviews in Endocrine and Metabolic DisordersSpringer Science+Business Media · Netherlands | 2.55Q1 | 6.27 0.40 up from 2014 | 87 | 43% | $5,590 | ||
10World Journal of DiabetesOAHong Kong SAR China | 2.54Q1 | 5.25 0.75 up from 2014 | 179 | 100% | — | ||
11Endocrinology and Metabolism Clinics of North AmericaElsevier BV · United States | 2.39Q1 | 4.98 0.47 down from 2014 | 157 | 18% | $3,540 | ||
12Journal of EndocrinologyBioscientifica · United Kingdom | 2.25Q1 | 5.24 0.64 up from 2014 | 470 | 95% | — | ||
13Current Diabetes ReportsSpringer Science+Business Media · United States | 2.16Q1 | 4.86 0.12 down from 2014 | 300 | 35% | $4,890 | ||
14Endocrine Related CancerBioscientifica · United Kingdom | 2.14Q1 | 5.56 0.57 up from 2014 | 363 | 94% | — | ||
15Current Opinion in Endocrinology Diabetes and ObesityLippincott Williams & Wilkins · United Kingdom | 2.12Q1 | 4.31 0.38 down from 2014 | 236 | 27% | — | ||
16European Journal of EndocrinologyOxford University Press · United Kingdom | 2.08Q1 | 5.17 0.09 up from 2014 | 707 | 26% | $4,292 | ||
17Diabetes Metabolic Syndrome and ObesityOADove Medical Press · New Zealand | 1.99Q1 | 5.51 0.75 up from 2014 | 153 | 100% | $2,836 | ||
18Therapeutic Advances in Endocrinology and MetabolismOASAGE Publishing · United Kingdom | 1.97Q1 | 3.73 0.09 up from 2014 | 50 | 100% | $2,650 | ||
19EndocrinologyOxford University Press · United States | 1.95Q1 | 4.61 0.57 down from 2014 | 1,515 | 54% | $3,750 | ||
20Frontiers in EndocrinologyOAFrontiers Media · Switzerland | 1.94Q1 | 5.21 0.44 up from 2014 | 615 | 100% | $3,801 | ||
21BMJ Open Diabetes Research & CareOABMJ · United Kingdom | 1.82Q1 | 3.16no 2014 value | 31 | 100% | $3,000 | — | |
22Cardiovascular DiabetologyOABioMed Central · United Kingdom | 1.78Q1 | 5.30 0.31 down from 2014 | 505 | 100% | $4,290 | ||
23ThyroidMary Ann Liebert, Inc. · United States | 1.67Q1 | 4.50 0.46 up from 2014 | 781 | 40% | — | ||
24Diabetes TherapyOAAdis, Springer Healthcare · United Kingdom | 1.67Q1 | 4.17 0.38 up from 2014 | 88 | 100% | $7,400 | ||
25Pediatric DiabetesWiley · Denmark | 1.62Q1 | 4.30 0.73 up from 2014 | 299 | 77% | $2,740 | ||
26Current Diabetes ReviewsBentham Science Publishers · Netherlands | 1.62Q1 | 3.29 0.24 down from 2014 | 148 | 24% | — | ||
27Diabetes Research and Clinical PracticeElsevier BV · Netherlands | 1.60Q1 | 4.08 0.55 up from 2014 | 853 | 20% | $4,410 | ||
28European Thyroid JournalOAKarger Publishers · Switzerland | 1.58Q1 | 3.90 1.99 up from 2014 | 121 | 98% | — | ||
29Journal of Diabetes & Metabolic DisordersSpringer Nature · United Kingdom | 1.58Q1 | 3.41 0.60 up from 2014 | 203 | 100% | $3,990 | ||
30Diabetes and Vascular Disease ResearchOASAGE Publishing · United Kingdom | 1.57Q1 | 4.14 0.17 up from 2014 | 152 | 63% | $2,100 | ||
31Diabetes/Metabolism Research and ReviewsWiley · United Kingdom | 1.56Q1 | 3.40 0.82 down from 2014 | 326 | 44% | $4,780 | ||
32MaturitasElsevier BV · Netherlands | 1.56Q1 | 3.87 0.23 up from 2014 | 600 | 9% | $4,390 | ||
33Diabetic MedicineWiley · United Kingdom | 1.55Q1 | 3.25 0.47 down from 2014 | 811 | 31% | $4,870 | ||
34Nutrition Metabolism and Cardiovascular DiseasesElsevier BV · Italy | 1.54Q1 | 3.74 0.46 up from 2014 | 446 | 28% | $3,000 | ||
35Clinical Pharmacology Advances and ApplicationsOADove Medical Press · New Zealand | 1.52Q1 | 3.60 0.47 up from 2014 | 59 | 100% | $2,320 | ||
36Journal of Diabetes ResearchOAHindawi Publishing Corporation · United Kingdom | 1.50Q1 | 3.35 0.02 up from 2014 | 265 | 100% | $2,760 | ||
37Clinical EndocrinologyWiley · United Kingdom | 1.50Q2 | 3.06 0.55 down from 2014 | 878 | 21% | $4,250 | ||
38Diabetes & MetabolismElsevier BV · Netherlands | 1.49Q2 | 3.60 0.30 up from 2014 | 260 | 2% | $4,490 | ||
39Diabetes & Metabolism JournalOAKorean Diabetes Association · South Korea | 1.47Q2 | 3.67 0.10 down from 2014 | 209 | 100% | $500 | ||
40International Journal of EndocrinologyOAHindawi Publishing Corporation · United Kingdom | 1.43Q2 | 3.33 0.25 up from 2014 | 572 | 100% | $2,830 | ||
41Clinical TherapeuticsElsevier BV · United States | 1.42Q2 | 3.19 0.12 up from 2014 | 697 | 57% | $4,240 | ||
42Lipids in Health and DiseaseOABioMed Central · United Kingdom | 1.40Q2 | 2.91 0.34 down from 2014 | 562 | 100% | $2,990 | ||
43Endocrine ConnectionsOABioscientifica · United Kingdom | 1.39Q2 | 3.63 1.06 up from 2014 | 87 | 100% | $2,146 | ||
44The Science of Diabetes Self-Management and CareSAGE Publishing · United States | 1.39Q2 | 2.49 0.08 up from 2014 | 200 | 25% | $4,400 | ||
45Diabetology & Metabolic SyndromeOABioMed Central · United Kingdom | 1.38Q2 | 3.00 0.76 down from 2014 | 274 | 100% | $2,890 | ||
46Hormone Research in PaediatricsKarger Publishers · Switzerland | 1.36Q2 | 3.30 0.74 up from 2014 | 344 | 27% | — | ||
47Journal of Diabetes and its ComplicationsElsevier BV · United States | 1.34Q2 | 3.18 0.23 down from 2014 | 441 | 23% | $3,760 | ||
48Diabetes Technology & TherapeuticsMary Ann Liebert, Inc. · United States | 1.32Q2 | 3.17 0.25 up from 2014 | 466 | 42% | — | ||
49Expert Review of Clinical PharmacologyTaylor & Francis · United Kingdom | 1.30Q2 | 2.66 0.12 up from 2014 | 221 | 32% | — | ||
50Journal of Diabetes InvestigationOAAsian Association for the Study of Diabetes · Australia | 1.29Q2 | 2.78 0.56 up from 2014 | 332 | 100% | $3,850 |
Subfields of Medicine, with Endocrinology, Diabetes and Metabolism highlighted.
- Surgery773
- Pulmonary and Respiratory Medicine297
- Public Health, Environmental and Occupational Health252
- Cardiology and Cardiovascular Medicine238
- Oncology188
- Infectious Diseases182
- Epidemiology176
- Neurology151
- Endocrinology, Diabetes and Metabolism141
- Radiology, Nuclear Medicine and Imaging138
- Physiology129
- Psychiatry and Mental health123
- Orthopedics and Sports Medicine95
- Pediatrics, Perinatology and Child Health85
- Dermatology74
- Ophthalmology74
- Hematology71
- Obstetrics and Gynecology61
- Rheumatology58
- Nephrology49
- Reproductive Medicine45
- Complementary and alternative medicine42
- Pharmacology42
- Emergency Medicine36
- Geriatrics and Gerontology36
- Otorhinolaryngology34
- Rehabilitation29
- Pathology and Forensic Medicine23
- Critical Care and Intensive Care Medicine22
- Genetics19
- Hepatology19
- Immunology and Allergy17
- Anesthesiology and Pain Medicine12
- Urology11
- Gastroenterology6
- Internal Medicine5
- Family Practice3
- Transplantation3
- Health Informatics1
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2015. Corpus-wide, 78.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
58 additional Endocrinology, Diabetes and Metabolism journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2012–2014, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2015. Publication window: 2012–2014. How these summaries are calculated
- Ranked journals
- 141
- Window papers (baseline)
- 61,715 +13.7% from indicator year 2012
- Median OJR
- 0.957 -2.3% from indicator year 2012
- Rising journals (2025)
- 11
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2012–2014 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 48 | 51 | 57 | 60 | 65 | 70 | 78 | 84 | 89 | 95 | 101 | 111 | 124 | 132 | 136 | 141 | 151 | 156 | 162 | 168 | 161 | 163 | 159 | 159 | 157 | 152 | |
| Window papers (baseline) | 21,857 | 24,171 | 25,806 | 27,521 | 27,880 | 30,069 | 32,732 | 36,738 | 40,740 | 46,752 | 50,540 | 53,888 | 54,290 | 56,103 | 58,424 | 61,715 | 64,393 | 66,581 | 68,391 | 70,385 | 72,729 | 75,894 | 79,750 | 82,000 | 83,560 | 87,039 | |
| Median OJR | 0.50 | 0.65 | 0.69 | 0.77 | 0.71 | 0.81 | 0.84 | 0.94 | 0.91 | 0.93 | 1.01 | 0.959 | 0.98 | 0.868 | 0.97 | 0.957 | 0.951 | 0.893 | 0.950 | 0.86 | 0.954 | 0.8896 | 0.8903 | 0.9170 | 0.9165 | 0.870 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.